查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1388188

口干症治疗药物市场、份额、规模、趋势、产业分析报告：按类型、产品、地区、细分市场预测，2023-2032年

Xerostomia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Type (OTC, Prescription), By Product, By Region, And Segment Forecasts, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris 市场研究的最新研究，到 2032 年，全球口干症治疗市场预计将达到 29.4 亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

口干症产品有优惠的报销政策，这意味着需要治疗口干症的患者可以更轻鬆地购买这些产品，因为他们的保险或医疗保健计划涵盖了部分费用，并且可以以较低的成本获得。 这鼓励患者寻求治疗，并最终推动对口干症相关产品和药物的需求。 口干症通常是干燥症、糖尿病、高血压和帕金森氏症等潜在疾病的症状或副作用。

随着医疗保健专业人员和公众对这些疾病的认识不断提高，越来越多的病例得到诊断和治疗。 这是因为医疗保健专业人员更有可能识别和治疗患有这些潜在疾病的患者的口干症状。 例如，高露洁棕榄公司和美国干燥症基金会等组织提供的统计数据强调了美国口干症和相关疾病的流行情况。 这些数字凸显了有效治疗的必要性以及解决口干症这一更大健康问题的症状的重要性。

干燥症基金会致力于提高人们对干燥症的认识，并为经常伴有口干症状的干燥症患者提供支持。 该基金会为患有这种自体免疫疾病的人们提供支持，并在美国和加拿大开展提高意识计画。 推出5年突破目标，旨在2017年将干燥症的诊断时间缩短至2.5年以内。 为此，我们的目标是加快干燥症的诊断和治疗，并解决口干问题，作为综合护理计划的一部分。

此外，该市场的领导公司认识到收购新创公司和实施意识计划的重要性。 例如，Orajel 与 iCrossing 发起了一项联合活动。 活动的目的是教育家长了解口腔护理的重要性，包括解决口干症等问题。 透过对公众进行有关口腔健康和口干等症状的教育，此类措施有助于提高对口干症及其治疗方法的认识。

口干症治疗药物市场报告重点

非处方药领域由于容易取得、价格实惠和有效率高而在市场上占据主导地位。

洁齿剂领域预计将快速增长，因为它专注于通过恢復唾液必需成分、钙和磷酸盐来改善唾液刺激剂，使其更加有效。Masu。

北美所占份额最大，主要是由于患者对口干症不良影响的认识以及医疗基础设施发达的有效治疗选择。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球口干症治疗市场洞察

  • 口干症治疗市场 - 产业概况
  • 口干症治疗药物市场动态
    • 促进因素和机会
      • 口腔健康状况日益普遍
      • 对安宁疗护和支持性照护的需求不断增加
    • 抑制因素和挑战
      • 一些口干症药物的副作用
  • PESTLE分析
  • 口干症治疗药物产业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球口干症治疗药物市场，依产品

  • 主要发现
  • 简介
  • 唾液兴奋剂
  • 唾液替代品
  • 牙膏

第 6 章全球口干症治疗药物市场（按类型）

  • 主要发现
  • 简介
  • 非处方药
  • 处方药

第 7 章全球口干症治疗药物市场（依地区）

  • 主要发现
  • 简介
    • 2019-2032 年口干症治疗药物市场评估（按地区）
  • 口干症治疗药物市场 - 北美
    • 北美：2019-2032 年口干症治疗药物市场（按类型）
    • 北美：口干症治疗药物市场（按产品），2019-2032 年
    • 口干症治疗药物市场 - 美国
    • 口干症治疗药物市场 - 加拿大
  • 口干症治疗药物市场 - 欧洲
    • 欧洲：口干症治疗药物市场（按类型），2019-2032 年
    • 欧洲：口干症治疗药物市场（按产品），2019-2032 年
    • 口干症治疗市场 - 英国
    • 口干症治疗药物市场 - 法国
    • 口干症治疗药物市场 - 德国
    • 口干症治疗药物市场 - 义大利
    • 口干症治疗药物市场 - 西班牙
    • 口干症治疗药物市场 - 荷兰
    • 口干症治疗药物市场 - 俄罗斯
  • 口干症治疗药物市场 - 亚太地区
    • 亚太地区：口干症治疗药物市场（按类型），2019-2032 年
    • 亚太地区：口干症治疗市场（依产品），2019-2032 年
    • 口干症治疗药物市场 - 中国
    • 口干症治疗药物市场 - 印度
    • 口干症治疗药物市场 - 马来西亚
    • 口干症治疗药物市场 - 日本
    • 口干症治疗药物市场 - 印度尼西亚
    • 口干症治疗药物市场 - 韩国
  • 口干症治疗药物市场 - 中东和非洲
    • 中东与非洲：2019-2032 年口干症治疗药物市场（按类型）
    • 中东和非洲：口干症治疗市场（按产品），2019-2032 年
    • 口干症治疗药物市场 - 沙乌地阿拉伯
    • 口干症治疗药物市场 - 阿联酋
    • 口干症治疗药物市场 - 以色列
    • 口干症治疗药物市场 - 南非
  • 口腔干燥症治疗药物市场 - 拉丁美洲
    • 拉丁美洲：口干症治疗药物市场（按类型），2019-2032 年
    • 拉丁美洲：口干症治疗药物市场（按产品），2019-2032 年
    • 口干症治疗药物市场 - 墨西哥
    • 口干症治疗药物市场 - 巴西
    • 口干症治疗药物市场 - 阿根廷

第 8 章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 9 章公司简介

  • Acacia Pharma
  • Church & Dwight Co., Inc.
  • Colgate-Palmolive Company
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Lupin Pharmaceuticals, Inc.
  • OraCoat
  • Parnell Pharmaceuticals, Inc.
  • Pendopharm
  • Pfizer, Inc.
  • Sun Pharmaceuticals Industries Ltd.
Product Code: PM1339

The global xerostomia therapeutics market size is expected to reach USD 2.94 billion by 2032, according to a new study by Polaris market research. The report "Xerostomia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Type (OTC, Prescription), By Product, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Favorable reimbursement policies for xerostomia products. This means that individuals who require treatment for xerostomia can access these products more easily and at reduced costs, as a portion of their expenses is covered by insurance or healthcare plans. This encourages patients to seek treatment, ultimately driving the demand for xerostomia-related products and medications. Xerostomia is often a symptom or side effect of underlying conditions such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease.

As awareness of these diseases increases among both healthcare professionals and the general population, more cases are being diagnosed and treated. This, in turn, has a positive impact on the demand for xerostomia treatments, as healthcare providers are more likely to identify and address dry mouth symptoms in patients with these underlying conditions. For instance, statistics provided by organizations like Colgate-Palmolive Company and the Sjogren Syndrome Foundation of America highlight the prevalence of xerostomia and related diseases in the United States. These figures underscore the need for effective treatments and the importance of addressing xerostomia as a symptom of larger health concerns.

Sjogren Syndrome Foundation of America's efforts to create awareness and support patients affected by Sjogren's syndrome, a condition often accompanied by xerostomia. The foundation conducts awareness programs and aids individuals suffering from this autoimmune disorder in both the United States & Canada. Introduced "5-Year Breakthrough Goal" with the objective of reducing the time it takes to diagnose the condition to less than 2.5 years by 2017. By doing so, they aimed to expedite the diagnosis and treatment of Sjogren's syndrome, which often includes addressing the issue of xerostomia as part of the comprehensive care plan.

Additionally, major players in the market recognize the importance of both acquiring emerging companies and conducting awareness programs. For instance, Orajel initiated a campaign in collaboration with iCrossing; the goal of this campaign was to educate parents about the significance of oral care, which includes addressing issues like xerostomia. By educating the public about oral health and conditions like dry mouth, these initiatives contribute to increasing awareness about xerostomia and its treatment options.

Xerostomia Therapeutics Market Report Highlights

The OTC segment dominated the market, as they are easily available, affordable, and have a higher efficacy rate

The dentifrices segment will grow rapidly, as they are more efficient as they focus on improving the salivary stimulants by restoring essential salivary components, Calcium, and phosphate

North America held the largest share, primarily due to patient awareness regarding the ill effects of xerostomia, effective treatment options via its well-developed medical infrastructure

The key market players include GlaxoSmithKline, Hikma Pharmaceuticals, Pendopharm, Sun Pharma, Lupin Pharmaceuticals, and Pfizer

Polaris market research has segmented the xerostomia therapeutics market report based on type, product, and region:

Xerostomia Therapeutics, Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • OTC
  • Prescription

Xerostomia Therapeutics, Product Outlook (Revenue - USD Billion, 2023 - 2032)

  • Salivary Stimulants
  • Salivary Substitutes
  • Dentifrices

Xerostomia Therapeutics, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Xerostomia Therapeutics Market Insights

  • 4.1. Xerostomia Therapeutics Market - Industry Snapshot
  • 4.2. Xerostomia Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased prevalence of oral health conditions
      • 4.2.1.2. Growing demand for palliative care and supportive therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects of some xerostomia medications
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Xerostomia Therapeutics Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Xerostomia Therapeutics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Xerostomia Therapeutics, by Product, 2019-2032 (USD Billion)
  • 5.3. Salivary Stimulants
    • 5.3.1. Global Xerostomia Therapeutics Market, by Salivary Stimulants, by Region, 2019-2032 (USD Billion)
  • 5.4. Salivary Substitutes
    • 5.4.1. Global Xerostomia Therapeutics Market, by Salivary Substitutes, by Region, 2019-2032 (USD Billion)
  • 5.5. Dentifrices
    • 5.5.1. Global Xerostomia Therapeutics Market, by Dentifrices, by Region, 2019-2032 (USD Billion)

6. Global Xerostomia Therapeutics Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 6.3. OTC
    • 6.3.1. Global Xerostomia Therapeutics Market, by OTC, by Region, 2019-2032 (USD Billion)
  • 6.4. Prescription
    • 6.4.1. Global Xerostomia Therapeutics Market, by Prescription, by Region, 2019-2032 (USD Billion)

7. Global Xerostomia Therapeutics Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Xerostomia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Xerostomia Therapeutics Market - North America
    • 7.3.1. North America: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.3.2. North America: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. Xerostomia Therapeutics Market - U.S.
      • 7.3.3.1. U.S.: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. Xerostomia Therapeutics Market - Canada
      • 7.3.4.1. Canada: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.4. Xerostomia Therapeutics Market - Europe
    • 7.4.1. Europe: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. Xerostomia Therapeutics Market - UK
      • 7.4.3.1. UK: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. Xerostomia Therapeutics Market - France
      • 7.4.4.1. France: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. Xerostomia Therapeutics Market - Germany
      • 7.4.5.1. Germany: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. Xerostomia Therapeutics Market - Italy
      • 7.4.6.1. Italy: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. Xerostomia Therapeutics Market - Spain
      • 7.4.7.1. Spain: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. Xerostomia Therapeutics Market - Netherlands
      • 7.4.8.1. Netherlands: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. Xerostomia Therapeutics Market - Russia
      • 7.4.9.1. Russia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.5. Xerostomia Therapeutics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. Xerostomia Therapeutics Market - China
      • 7.5.3.1. China: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. Xerostomia Therapeutics Market - India
      • 7.5.4.1. India: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. Xerostomia Therapeutics Market - Malaysia
      • 7.5.5.1. Malaysia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. Xerostomia Therapeutics Market - Japan
      • 7.5.6.1. Japan: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. Xerostomia Therapeutics Market - Indonesia
      • 7.5.7.1. Indonesia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. Xerostomia Therapeutics Market - South Korea
      • 7.5.8.1. South Korea: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.6. Xerostomia Therapeutics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. Xerostomia Therapeutics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. Xerostomia Therapeutics Market - UAE
      • 7.6.4.1. UAE: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. Xerostomia Therapeutics Market - Israel
      • 7.6.5.1. Israel: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. Xerostomia Therapeutics Market - South Africa
      • 7.6.6.1. South Africa: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.7. Xerostomia Therapeutics Market - Latin America
    • 7.7.1. Latin America: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. Xerostomia Therapeutics Market - Mexico
      • 7.7.3.1. Mexico: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. Xerostomia Therapeutics Market - Brazil
      • 7.7.4.1. Brazil: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. Xerostomia Therapeutics Market - Argentina
      • 7.7.5.1. Argentina: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Acacia Pharma
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Church & Dwight Co., Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Colgate-Palmolive Company
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. GlaxoSmithKline plc
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Hikma Pharmaceuticals PLC
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Lupin Pharmaceuticals, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. OraCoat
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Parnell Pharmaceuticals, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Pendopharm
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Pfizer, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Sun Pharmaceuticals Industries Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables

  • Table 1 Global Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Xerostomia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 5 North America: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 6 U.S.: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 7 U.S.: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 8 Canada: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 9 Canada: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 10 Europe: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 11 Europe: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 12 UK: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 13 UK: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 14 France: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 15 France: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Germany: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Germany: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 18 Italy: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 19 Italy: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Spain: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 21 Spain: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Russia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Russia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 China: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 29 China: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 30 India: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 31 India: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Japan: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 35 Japan: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 38 South Korea: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 39 South Korea: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 44 UAE: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 45 UAE: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 46 Israel: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Israel: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 48 South Africa: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 49 South Africa: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Latin America: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Latin America: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Mexico: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 53 Mexico: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Brazil: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Brazil: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Argentina: Xerostomia Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Argentina: Xerostomia Therapeutics Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Xerostomia Therapeutics Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Type
  • Figure 7 Global Xerostomia Therapeutics Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Product
  • Figure 9 Global Xerostomia Therapeutics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10 Xerostomia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Xerostomia Therapeutics Market